-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra-1416-p007-1-ef.pdf
November 01, 2015 - Timeliness of Confirmatory Testing for Sickle Cell Disease: Timeliness of Antibiotic Prophylaxis for … Children with Sickle Cell Anemia
Timeliness of Confirmatory Testing
for Sickle Cell Disease
Timeliness … Prophylaxis for
Children with Sickle Cell Anemia
Measure Developer: Quality Measurement, Evaluation, Testing … University of Michigan
Numerator Denominator Exclusions Data Source(s)
Timeliness of Confirmatory Testing … tested positive
for sickle cell disease
(SCD) through
newborn screening,
received confirmatory
testing
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra-1416-p007-1-ef.pdf
November 01, 2015 - Timeliness of Confirmatory Testing for Sickle Cell Disease: Timeliness of Antibiotic Prophylaxis for … Children with Sickle Cell Anemia
Timeliness of Confirmatory Testing
for Sickle Cell Disease
Timeliness … Prophylaxis for
Children with Sickle Cell Anemia
Measure Developer: Quality Measurement, Evaluation, Testing … University of Michigan
Numerator Denominator Exclusions Data Source(s)
Timeliness of Confirmatory Testing … tested positive
for sickle cell disease
(SCD) through
newborn screening,
received confirmatory
testing
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra-1416-p007-1-ef.pdf
November 01, 2015 - Timeliness of Confirmatory Testing for Sickle Cell Disease: Timeliness of Antibiotic Prophylaxis for … Children with Sickle Cell Anemia
Timeliness of Confirmatory Testing
for Sickle Cell Disease
Timeliness … Prophylaxis for
Children with Sickle Cell Anemia
Measure Developer: Quality Measurement, Evaluation, Testing … University of Michigan
Numerator Denominator Exclusions Data Source(s)
Timeliness of Confirmatory Testing … tested positive
for sickle cell disease
(SCD) through
newborn screening,
received confirmatory
testing
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra-1416-p007-1-ef.pdf
November 01, 2015 - Timeliness of Confirmatory Testing for Sickle Cell Disease: Timeliness of Antibiotic Prophylaxis for … Children with Sickle Cell Anemia
Timeliness of Confirmatory Testing
for Sickle Cell Disease
Timeliness … Prophylaxis for
Children with Sickle Cell Anemia
Measure Developer: Quality Measurement, Evaluation, Testing … University of Michigan
Numerator Denominator Exclusions Data Source(s)
Timeliness of Confirmatory Testing … tested positive
for sickle cell disease
(SCD) through
newborn screening,
received confirmatory
testing
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra-1416-p007-1-ef.pdf
November 01, 2015 - Timeliness of Confirmatory Testing for Sickle Cell Disease: Timeliness of Antibiotic Prophylaxis for … Children with Sickle Cell Anemia
Timeliness of Confirmatory Testing
for Sickle Cell Disease
Timeliness … Prophylaxis for
Children with Sickle Cell Anemia
Measure Developer: Quality Measurement, Evaluation, Testing … University of Michigan
Numerator Denominator Exclusions Data Source(s)
Timeliness of Confirmatory Testing … tested positive
for sickle cell disease
(SCD) through
newborn screening,
received confirmatory
testing
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra-1416-p007-1-ef.pdf
November 01, 2015 - Timeliness of Confirmatory Testing for Sickle Cell Disease: Timeliness of Antibiotic Prophylaxis for … Children with Sickle Cell Anemia
Timeliness of Confirmatory Testing
for Sickle Cell Disease
Timeliness … Prophylaxis for
Children with Sickle Cell Anemia
Measure Developer: Quality Measurement, Evaluation, Testing … University of Michigan
Numerator Denominator Exclusions Data Source(s)
Timeliness of Confirmatory Testing … tested positive
for sickle cell disease
(SCD) through
newborn screening,
received confirmatory
testing
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra-1416-p007-1-ef.pdf
November 01, 2015 - Timeliness of Confirmatory Testing for Sickle Cell Disease: Timeliness of Antibiotic Prophylaxis for … Children with Sickle Cell Anemia
Timeliness of Confirmatory Testing
for Sickle Cell Disease
Timeliness … Prophylaxis for
Children with Sickle Cell Anemia
Measure Developer: Quality Measurement, Evaluation, Testing … University of Michigan
Numerator Denominator Exclusions Data Source(s)
Timeliness of Confirmatory Testing … tested positive
for sickle cell disease
(SCD) through
newborn screening,
received confirmatory
testing
-
psnet.ahrq.gov/node/42582/psn-pdf
September 18, 2013 - When diagnostic testing leads to harm: a new outcomes-
based approach for laboratory medicine. … When diagnostic testing leads to harm: a new outcomes-based approach
for laboratory medicine. … https://psnet.ahrq.gov/issue/when-diagnostic-testing-leads-harm-new-outcomes-based-approach-
laboratory-medicine … This commentary recommends an approach to examine laboratory testing and identify weaknesses that … https://psnet.ahrq.gov/issue/when-diagnostic-testing-leads-harm-new-outcomes-based-approach-laboratory-medicine
-
www.uspreventiveservicestaskforce.org/uspstf/document/modeling-study/cervical-cancer-screening
August 21, 2018 - hrHPV testing with cytology triage. … to hrHPV testing or cotesting. … testing alone and cotesting. … Human papillomavirus testing 2007-2012: co-testing and triage utilization and impact on subsequent clinical … but not diagnostic (ie, colposcopy and biopsy) testing.
-
psnet.ahrq.gov/node/35700/psn-pdf
February 15, 2010 - Point-of-care testing error: sources and amplifiers,
taxonomy, prevention strategies, and detection … Point-of-care testing error: sources and amplifiers, taxonomy, prevention strategies,
and detection … https://psnet.ahrq.gov/issue/point-care-testing-error-sources-and-amplifiers-taxonomy-prevention-
strategies-and-detection … The investigators found point-of-care testing errors to be relatively common and identified sources … https://psnet.ahrq.gov/issue/point-care-testing-error-sources-and-amplifiers-taxonomy-prevention-strategies-and-detection
-
psnet.ahrq.gov/node/37837/psn-pdf
June 11, 2008 - Testing process errors and their harms and
consequences reported from family medicine practices: a … Testing process errors and their harms and consequences
reported from family medicine practices: a study … https://psnet.ahrq.gov/issue/testing-process-errors-and-their-harms-and-consequences-reported-family- … based in eight
outpatient family medicine clinics to examine the types and severity of errors in the testing … A
companion article evaluated factors that reduced harm to patients from testing errors.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/-6kN7TPcfEj2owG4GTN2jA
June 01, 2012 - The benefits of
screening with
co-testing
(cytology/HPV
testing) every 5 years
outweigh the harms … to 65 Years
Women Aged 21 Women Aged 30
HPV testing combined with cytology (co-testing) every 5 years … Among women aged 30 to 65 years, HPV
testing combined with cytology (co-testing) every 5 years
offers … may increase with HPV testing. … Women aged 30 to 65 years should be
screened with cytology and HPV testing (co-testing) every
5 years
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/TEqfQsqZ92eykPeTQBZx-h
March 12, 2012 - Grade: A
Screen with cytology
every 3 years or
co-testing
(cytology/HPV testing)
every 5 years … Grade: D
Do not screen with
HPV testing (alone or
with cytology)
Grade: D
Risk Assessment … HPV testing combined with cytology (co-testing) every 5 years in women ages 30 to 65 years offers a comparable … The benefits of
screening with co-testing
(cytology/HPV testing)
every 5 years outweigh
the harms … The potential harms of
screening with HPV
testing (alone or with
cytology) outweigh the
potential
-
psnet.ahrq.gov/node/39740/psn-pdf
August 11, 2010 - Development and pilot testing of guidelines to monitor
high-risk medications in the ambulatory setting … Development and pilot testing of guidelines to monitor high-risk
medications in the ambulatory setting … https://psnet.ahrq.gov/issue/development-and-pilot-testing-guidelines-monitor-high-risk-medications- … Pilot testing revealed that the developed guidelines were not being
consistently followed, with infrequently … https://psnet.ahrq.gov/issue/development-and-pilot-testing-guidelines-monitor-high-risk-medications-ambulatory-setting
-
psnet.ahrq.gov/node/46102/psn-pdf
May 31, 2017 - Improving infusion pump safety through usability testing. … Improving infusion pump safety through usability testing. … https://psnet.ahrq.gov/issue/improving-infusion-pump-safety-through-usability-testing
Usability testing … This
commentary describes the testing processes used for an infusion pump integration initiative. … https://psnet.ahrq.gov/issue/improving-infusion-pump-safety-through-usability-testing
https://psnet.ahrq.gov
-
psnet.ahrq.gov/node/44828/psn-pdf
November 18, 2016 - The Healthcare Complaints Analysis Tool: development
and reliability testing of a method for service … The Healthcare Complaints Analysis Tool: development and reliability testing of a
method for service … https://psnet.ahrq.gov/issue/healthcare-complaints-analysis-tool-development-and-reliability-testing- … method-service
This study describes the development and validity testing of a new tool for coding … https://psnet.ahrq.gov/issue/healthcare-complaints-analysis-tool-development-and-reliability-testing-method-service
-
psnet.ahrq.gov/node/43005/psn-pdf
March 05, 2014 - "Chance favors only the prepared mind": preparing minds
to systematically reduce hazards in the testing … "Chance favors only the prepared mind": preparing minds to
systematically reduce hazards in the testing … psnet.ahrq.gov/issue/chance-favors-only-prepared-mind-preparing-minds-systematically-reduce-
hazards-testing … analysis methodology, this study
sought to prospectively identify safety hazards in the laboratory testing … psnet.ahrq.gov/issue/chance-favors-only-prepared-mind-preparing-minds-systematically-reduce-hazards-testing
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-533_05-24-2013.pdf
January 01, 2013 - Testing … The current strategy for diagnosing CD involves serial serologic and
histopathologic testing. … After initial evaluation and testing for iron, folate and vitamin B12
deficiencies and ruling out other … Objective 4 - Expected consequences of testing for CD (Celiac 4)
a. … What are the expected consequences of testing for CD in the following populations:
i.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND-533_05-24-2013.pdf
January 01, 2013 - Testing … The current strategy for diagnosing CD involves serial serologic and
histopathologic testing. … After initial evaluation and testing for iron, folate and vitamin B12
deficiencies and ruling out other … Objective 4 - Expected consequences of testing for CD (Celiac 4)
a. … What are the expected consequences of testing for CD in the following populations:
i.
-
psnet.ahrq.gov/node/43698/psn-pdf
November 19, 2014 - Alcohol and drug testing of health professionals following
preventable adverse events: a bad idea. … Alcohol and drug testing of health professionals following preventable adverse events: a bad idea. … https://psnet.ahrq.gov/issue/alcohol-and-drug-testing-health-professionals-following-preventable-adverse … This commentary explains why implementing a formal process for substance abuse testing
following an … https://psnet.ahrq.gov/issue/alcohol-and-drug-testing-health-professionals-following-preventable-adverse-events-bad-idea